Industry Watch

Preventing contamination in an ever changing industry

11 July 2018
By ChargePoint Technology

As more pharmaceutical businesses focus on creating innovative, targeted therapies, the industry is having to adapt like never before. Contamination control in particular has advanced and developed significantly. 

Global product manager, Michael Avraam, discusses how businesses are transforming their approaches to containment and the safe development of pharmaceutical products in an article for Pharmaceutical Manufacturing. 

Sterile drug manufacturing techniques and technology

29 March 2018
By ChargePoint Technology

Ensuring a safe and sterile environment for active pharmaceutical ingredients (APIs) and formulation ingredients is fundamental during aseptic processing. Air filtration systems, materials transfer and of course operators themselves bring an abundance of potential hazards during the manufacturing process. Therefore there have been many techniques developed in order to provide a risk-averse and contamination-free environment for production. 

ChargePoint Technology's global product manager, Christian Dunne discusses the various techniques available with Pharmaceutical Manufacturing. From barrier technologies such as isolators and RABS to split butterfly valve technology (SBV), Christian weighs up the benefits of each and their place within the sector. You can read the full article here 

Mitigating the risk: manufacturing high potency drugs

27 March 2018
By ChargePoint Technology

As the demand for high potency drug handling continues to rise, as does the need for high containment facilities. However, currently many manufacturing facilities are unable to manage the upsurge and are needing to upgrade, develop and sometimes even construct new facilities to handle the significant demand. Under these circumstances it is more important than ever for companies to select the right partners with specialist containment solutions so they can adapt to the industry changes and containment challenges ahead. 

Our very own Michael Avraam discusses the risks, challenges and innovative steps now being taken in today's high potency sector with CPhI Online. You can read the full Q&A here.

Trends for 2018: Pharma's Fantastic Four

27 February 2018
By ChargePoint Technology

As 2018 gets into full swing, we enter into discussions with other pharmaceutical industry experts in European Pharmaceutical Manufacturer...

An Industry Review of 2017 - Part 2

19 December 2017
By ChargePoint Technology

Looking back at 2017...

As the year draws to a close, we have reached a natural point of reflection here at ChargePoint. 2017 has been yet another significant year for the pharmaceutical industry, which is experiencing a notable period of change. The last few years have seen the industry begin to transform; with the growing use of data and technology, increasing development of high potency products, the enforcement of serilisation regulations in the US, and an ever increasing move towards single-use technology. Importantly for ChargePoint, the biopharma boom continues and therefore the demand for containment, particularly from therapeutic areas such as oncology and hormonal drug products, continues to grow.



Subscribe to RSS Feed